Shandong Xinhua Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
389.00
578.00
587.00
548.00
508.00
465.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-494.00
-823.00
-968.00
-331.00
-666.00
-433.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
589.00
407.00
302.00
890.00
323.00
287.00
Cash Flow from Investing Activities
-119.00
-238.00
-346.00
-231.00
-276.00
-325.00
Cash Flow from Financing Activities
-318.00
200.00
-216.00
-195.00
-189.00
214.00
Net Cash Inflow / Outflow
158.00
385.00
-253.00
481.00
-152.00
162.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
7.00
16.00
7.00
18.00
-9.00
-13.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shandong Xinhua Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
389.838243247704
729.631376345522
-340.00
-46.57%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-494.402570911804
59.4448044089604
-553.00
-931.70%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
589.469301797286
686.67519637262
-97.00
-14.16%
Cash Flow from Investing Activities
-119.716395572031
-1463.37906177012
1,344.00
91.82%
Cash Flow from Financing Activities
-318.899080177566
1241.86238341258
-1,559.00
-125.68%
Net Cash Inflow / Outflow
158.70253852426
468.035256746484
-310.00
-66.09%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
7.84871247656759
2.87673873139756
5.00
172.83%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 44.68% vs 34.85% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
589.47
407.44
44.68%






